Aarhus University Hospital hosts the Danish Centre for Particle Therapy, the national proton facility opened in 2019; its oncology department under Jens Overgaard has run the DAHANCA head and neck trials that established accelerated fractionation and the radiosensitiser nimorazole.
Aarhus University Hospital hosts the Danish Centre for Particle Therapy, the country's national proton facility, which opened in 2019 with Varian ProBeam gantries and treats patients from across Denmark within randomised trials. Its experimental clinical oncology department under Jens Overgaard has run the DAHANCA head and neck cancer trials for decades, establishing accelerated fractionation and the hypoxic radiosensitiser nimorazole, and pioneered clinical hyperthermia with radiotherapy for melanoma. The hospital is a major transplant, urological cancer and gastrointestinal surgery centre, contributes to Danish Breast Cancer Group trials, and leads registry-based studies through Aarhus University's clinical epidemiology department.
From OpenAlex, oncology works in the last five years (2022 to 2026, current year in progress); counted on 2026-09-17.
Matched to Aarhus University Hospital, including child institutions. 624 works · 4,497 citations · 81% open access · 7% clinical trials · 3% reviews.
Pioneering radiation oncologist at Aarhus who led the DAHANCA trials on hypoxia modification and radiotherapy for head and neck cancer.
Chief Executive Officer of Aarhus University Hospital, Denmark's largest hospital and a major cancer treatment centre.
It reframes the blood test from a yes-or-no residual disease result into a measure of how well chemotherapy is working and how fast a relapse is coming, which is what an escalation trial would need.
It showed that serial rather than single testing is what makes residual disease detection work, and it set the sampling schedule most later studies have used.
Shares Proton therapy machines: cyclotrons, synchrotrons and single-room systems, Proton therapy, SBRT / SABR (stereotactic radiotherapy), Head and neck squamous cell carcinoma.
Shares Proton therapy machines: cyclotrons, synchrotrons and single-room systems, Proton therapy, SBRT / SABR (stereotactic radiotherapy), Head and neck squamous cell carcinoma.
Shares Varian (Siemens Healthineers), Surgery and radiotherapy cure most, get least, SBRT / SABR (stereotactic radiotherapy), Head and neck squamous cell carcinoma.
Shares Proton therapy machines: cyclotrons, synchrotrons and single-room systems, Proton therapy, Head and neck squamous cell carcinoma, IMRT / IGRT (modern external beam).
Shares Varian (Siemens Healthineers), Proton therapy machines: cyclotrons, synchrotrons and single-room systems, Proton therapy, SBRT / SABR (stereotactic radiotherapy).
Shares Varian (Siemens Healthineers), Surgery and radiotherapy cure most, get least, Proton therapy, IMRT / IGRT (modern external beam).
Shares Surgery and radiotherapy cure most, get least, SBRT / SABR (stereotactic radiotherapy), IMRT / IGRT (modern external beam), HR-positive / HER2-negative breast cancer.
Shares Odense University Hospital, Rigshospitalet, Copenhagen University Hospital.